10x Genomics, Inc. TXG Business Segments
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Total Revenue by Product | |||||
| Single Cell | $363.21M-2.4% | $372.31M-11.4% | $420.32M— | —— | |
| Spatial | $143.98M+18.9% | $121.12M+104% | $59.24M+68.5% | $35.16M+26.2% | |
| Revenue by Product | |||||
| License and royalty revenue | $46.14M+14,272% | $321K— | $0— | —— | |
| Products and services revenue | $596.69M-2.3% | $610.46M-1.3% | $618.73M— | —— | |
| Services | $32.73M+34.6% | $24.32M+54.9% | $15.7M+86.4% | $8.43M+15.8% | |
| Spatial | $34.11M-40.7% | $57.5M-23.9% | $75.61M+446% | $13.84M+4,469% | |
| Revenue by Geography | |||||
| Americas (excluding United States) | $12.26M-8.8% | $13.45M+2.6% | $13.1M+49.0% | $8.79M+30.9% | |
| Asia-Pacific (excluding China) | $52.07M+13.3% | $45.96M-12.1% | $52.29M+26.9% | $41.21M+5.4% | |
| China | $70.26M+22.6% | $57.3M+12.4% | $50.97M-20.8% | $64.36M-17.4% | |
| Europe, Middle East and Africa | $161.72M+1.2% | $159.76M+12.3% | $142.28M+21.5% | $117.07M+7.9% | |
| United States | $346.51M+3.6% | $334.32M-7.2% | $360.09M+26.4% | $284.99M+10.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does 10x Genomics, Inc. break its business down?
- 10x Genomics, Inc. (TXG) reports total revenue by product across 2 parts — Single Cell and Spatial. Each is extracted from the segment footnotes and tracked over time.
- Where does 10x Genomics, Inc.'s segment data come from?
- Segment breakdowns are pulled from the segment footnotes in 10x Genomics, Inc.'s SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.